Corsenbio Consulting Ltd 15170008 false 2023-09-27 2024-09-30 2024-09-30 The principal activity of the company is Biomedical consulting Digita Accounts Production Advanced 6.30.9574.0 true 15170008 2023-09-27 2024-09-30 15170008 2024-09-30 15170008 core:CurrentFinancialInstruments core:WithinOneYear 2024-09-30 15170008 bus:Micro-entities 2023-09-27 2024-09-30 15170008 bus:AuditExemptWithAccountantsReport 2023-09-27 2024-09-30 15170008 bus:FilletedAccounts 2023-09-27 2024-09-30 15170008 bus:SmallCompaniesRegimeForAccounts 2023-09-27 2024-09-30 15170008 bus:RegisteredOffice 2023-09-27 2024-09-30 15170008 bus:Director1 2023-09-27 2024-09-30 15170008 bus:Director2 2023-09-27 2024-09-30 15170008 bus:PrivateLimitedCompanyLtd 2023-09-27 2024-09-30 15170008 countries:AllCountries 2023-09-27 2024-09-30 iso4217:GBP xbrli:pure

Registration number: 15170008

Corsenbio Consulting Ltd

Unaudited Filleted Financial Statements

for the Period from 27 September 2023 to 30 September 2024

image-name
 

Corsenbio Consulting Ltd

Contents

Company Information

1

Balance Sheet

2 to 3

Notes to the Unaudited Financial Statements

2

 

Corsenbio Consulting Ltd

Company Information

Directors

J Charton

F Charlton

Registered office

Lloyds Bank House
Bellingham
Hexham
Northumberland
NE48 2AZ

Accountants

TyneRede Accountancy Ltd
Chartered Certified Accountant
Lloyds Bank House
Bellingham
Hexham
Northumberland
NE48 2AZ

 

Corsenbio Consulting Ltd

(Registration number: 15170008)
Balance Sheet as at 30 September 2024

2024
£

Fixed assets

167

Current assets

20,555

Creditors: Amounts falling due within one year

(19,861)

Net current assets

694

Total assets less current liabilities

861

Accruals and deferred income

(924)

 

(63)

Capital and reserves

(63)

1

General information

The company is a private company limited by share capital, incorporated in England & Wales.

The address of its registered office is:
Lloyds Bank House
Bellingham
Hexham
Northumberland
NE48 2AZ
England

These financial statements were authorised for issue by the Board on 26 November 2024.

Basis of preparation

The financial statements have been prepared under the historical cost convention and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime'.

2

Staff numbers

The average number of persons employed by the company (including directors) during the period, was 2.

3

Financial commitments, guarantees and contingencies

Amounts not provided for in the balance sheet

The total amount of financial commitments not included in the balance sheet is £Nil.

For the financial period ending 30 September 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

 

Corsenbio Consulting Ltd

(Registration number: 15170008)
Balance Sheet as at 30 September 2024

The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 26 November 2024 and signed on its behalf by:
 

.........................................
J Charton
Director